CHEManager – The EU Commission has launched the pharmaceutical package. It is intended to redefine the rules of the game in the industry for the next decades: Who will have access to medicines and under what conditions? What will the framework conditions for the pharmaceutical industry look like in the future? These and other central questions are to be answered by the EU Commission’s pharmaceutical package. In the opinion of pharmaceutical associations and experts, the first impact has not been successful. Read more.